FAQ
Below you can find answers to some of the most commonly asked questions about our GLP-1 weight loss and other programs:
Frequently Asked Questions
All costs to see the physician and get a prescription are covered by a valid OHIP card.
Obesity is defined as an excessive accumulation of body fat that presents a risk to health, typically measured using the Body Mass Index (BMI). A BMI of 30 or higher is generally considered indicative of obesity in adults, though factors such as muscle mass, bone density, and overall body composition can influence this classification. Obesity is associated with numerous health issues including heart disease, diabetes, hypertension, and certain cancers, and it results from a combination of genetic, behavioral, and environmental factors. affecting children.
Semaglutide Injection is a once-a-week dose that works by mimicking hormones that target areas of the brain involved in regulating appetite and food intake. This can help you eat less and lead to weight loss.
- Once a week
- Taken on the same day each week, any time of day, with or without food.
- Detailed dosing schedule will be provided with Home kit.
No. We will not act as your family doctor. We will however follow and treat you for your mental health conditions.
All conditions listed on this site and those related to them or their treatment are covered.
Medical visits for obesity are covered by OHIP if your BMI if over 27. If you need a consultation about your weight and your BMI falls below this, you will be responsible for the costs of the doctor visit, which are $70 per visit.
We are not a pharmacy and thus not involved in the sale of your medications. You can consult with the pharmacy of choice about cost of the medications or whether the prescribed medications are covered by your medication insurance plan.
At this time, we do not provided this service.
An assessment by our physician as well as a blood test documenting low levels of testosterone and ruling out other causes of your symptoms.
Healthy eating and activity are recommended. You can follow our simple guide which will be given to you at the time of your visit.
In the Semaglutide Treatment Effect in People With Obesity (STEP) trials, it was discovered that obese patients who took 2.4 mg of Semaglutide on a weekly basis experienced an average weight loss of 6% by week 12. This weight loss was further demonstrated to increase to 12% of their body weight by week 28.
If you’re using semaglutide for chronic weight management, you can expect to observe initial results within the first month, albeit moderate at lower doses. As the dosage incrementally increases, you’ll start shedding more excess weight, with the most significant loss occurring between weeks 8 and 28.